Virtu Financial’s Capricor Therapeutics CAPR Stock Holding History

Virtu Financial’s Portfolio CAPR Stock Details CAPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$215K	Buy	+7,058	New	+$188K	0.01%	992
2024 Q4	–	Sell	-30,112	Closed	-$458K	–	1584
2024 Q3	$458K	Buy	+30,112	New	+$149K	0.03%	488
2023 Q2	–	Sell	-16,895	Closed	-$71K	–	1549
2023 Q1	$71K	Buy	+16,895	New	+$72.7K	0.01%	1043
2021 Q4	–	Sell	-55,200	Closed	-$222K	–	1742
2021 Q3	$222K	Buy	+55,200	New	+$251K	0.02%	869
2020 Q3	–	Sell	-57,444	Closed	-$264K	–	1099
2020 Q2	$264K	Buy	+57,444	New	+$250K	0.03%	610
2019 Q1	–	Sell	-2,025	Closed	-$8K	–	1440
2018 Q4	$8K	Buy	2,025 +913	+82%	+$7.25K	﹤0.01%	1457
2018 Q3	$12K	Sell	1,112 -4,564	-80%	-$54.4K	﹤0.01%	1438
2018 Q2	$76K	Buy	5,676 +435	+8%	+$5.92K	﹤0.01%	1698
2018 Q1	$71K	Buy	+5,241	New	+$90.9K	﹤0.01%	1645

Other funds holding CAPR

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JHC

Jones Hill Capital New York $466M AUM

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Virtu Financial's CAPR Position: Q1 2026 in Review

Virtu Financial opened a new position in Capricor Therapeutics (CAPR) in Q1 2026: 7,058 shares worth $215K. The stake represents 0.01% of the portfolio and ranks #992 among its holdings. This is a return to the name: Virtu Financial previously reported a position in CAPR as recently as Q3 2024.

Virtu Financial first reported a position in CAPR in Q1 2018 and has held it in 9 quarters since. The position peaked at $458K in Q3 2024. 177 funds tracked by Wall St. Rank hold CAPR as of Q1 2026.

Virtu Financial held 7,058 shares of Capricor Therapeutics worth $215K as of Q1 2026.
Capricor Therapeutics was a new Virtu Financial position in Q1 2026.
Capricor Therapeutics made up 0.01% of Virtu Financial's portfolio in Q1 2026, its #992 holding.
Virtu Financial first reported a position in Capricor Therapeutics in Q1 2018 and has held it in 9 quarters since.
Virtu Financial's Capricor Therapeutics position peaked at $458K in Q3 2024.
177 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.